Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein

被引:142
作者
Schüttler, CG
Fiedler, N
Schmidt, K
Repp, R
Gerlich, WH
Schaefer, S
机构
[1] Univ Giessen, Inst Med Virol, D-35392 Giessen, Germany
[2] Univ Erlangen Nurnberg, Klin Kinder & Jugendliche, D-91054 Erlangen, Germany
[3] Univ Rostock, Inst Med Mikrobiol, Abt Virol, D-18055 Rostock, Germany
关键词
coinfection; trans-repression; hepatitis B virus basic core promoter; hepatitis C virus genotype; hepatitis C virus core protein;
D O I
10.1016/S0168-8278(02)00296-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Epidemiological studies have shown that coinfection or superinfection with hepatitis B virus (HBV) and C virus (HCV) frequently leads to the suppression of hepatitis B virus replication. The mechanism of this phenomenon is still unclear. Shih et al. [j Virol 1993;67:5823] reported a direct suppression of HBV replication by the core protein of HCV. The target structure of HCV core protein in this system remained unclear. Methods: As HCV core protein has been shown to influence expression from transcriptional elements, we studied whether HCV core protein altered the activity of the two HBV enhancers 1 and 2. Luciferase vectors for HBV enhancers 1 or 2 were cotransfected with expression constructs for HCV core protein in murine and human hepatocyte lines. Results: Full-length HCV core protein suppressed the HBV enhancer 1 up to 11-fold, the enhancer 2 3-4-fold. Suppression of HBV enhancer 1 by HCV core from genotype 1b was stronger than by HCV core of genotypes 3a or 1a. Carboxyterminally truncated core proteins had lower or no suppression activity. Conclusions: These data suggest that HCV core protein may directly repress transcription of the HBV RNAs. This trans-repression may contribute to suppression of HBV replication in patients coinfected with both viruses. (C) 2002 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:855 / 862
页数:8
相关论文
共 52 条
[1]   CONTROLLED SYNTHESIS OF HBSAG IN A DIFFERENTIATED HUMAN-LIVER CARCINOMA-DERIVED CELL-LINE [J].
ADEN, DP ;
FOGEL, A ;
PLOTKIN, S ;
DAMJANOV, I ;
KNOWLES, BB .
NATURE, 1979, 282 (5739) :615-616
[2]  
Ausubel FM., 1998, CURRENT PROTOCOLS MO
[3]   High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen [J].
Berger, A ;
Doerr, HW ;
Rabenau, HF ;
Weber, B .
INTERVIROLOGY, 2000, 43 (02) :71-76
[4]   Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein [J].
Bergqvist, A ;
Rice, CM .
JOURNAL OF VIROLOGY, 2001, 75 (02) :772-781
[5]   The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro [J].
Bock, CT ;
Malek, NP ;
Tillmann, HL ;
Manns, MP ;
Trautwein, C .
JOURNAL OF VIROLOGY, 2000, 74 (05) :2193-2202
[6]   NON-A-HEPATITIS, NON-B-HEPATITIS IN CHIMPANZEES - INTERFERENCE WITH ACUTE HEPATITIS-A VIRUS AND CHRONIC HEPATITIS-B VIRUS-INFECTIONS [J].
BRADLEY, DW ;
MAYNARD, JE ;
MCCAUSTLAND, KA ;
MURPHY, BL ;
COOK, EH ;
EBERT, JW .
JOURNAL OF MEDICAL VIROLOGY, 1983, 11 (03) :207-213
[7]   INTERFERENCE BETWEEN NON-A-HEPATITIS, NON-B-HEPATITIS AND HEPATITIS-B VIRUS-INFECTION IN CHIMPANZEES [J].
BROTMAN, B ;
PRINCE, AM ;
HUIMA, T ;
RICHARDSON, L ;
VANDENENDE, MC ;
PFEIFER, U .
JOURNAL OF MEDICAL VIROLOGY, 1983, 11 (03) :191-205
[8]   Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].
Cacciola, I ;
Pollicino, T ;
Squadrito, G ;
Cerenzia, G ;
Orlando, ME ;
Raimondo, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26
[9]  
Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt
[10]  
347::AID-IJC4&gt